About 100 reports

Kaposi sarcoma induced due to HIV/ AIDS is one of the most common causes of the disease and acts as a major driver for the market.

  • Chemotherapy
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

Develops drugs for oncology, bone and joint diseases, central nervous system (CNS) disorders, and autoimmune diseases.

  • Chemotherapy
  • World
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer Inc.

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd

Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.

  • Chemotherapy
  • China
  • Demand
  • Trade
  • Hainan Haiyao Company Limited

Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.

  • Chemotherapy
  • China
  • Demand
  • Market Size
  • Trade

Genes & Diseases; ##(##): ##-## Cancer Network.

  • Chemotherapy
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.

Roche is the world leader in in-vitro diagnostics and drugs for cancer Page## Chapter VII SKIN CANCER TREATMENT DRUGS PRODUCER DIRECTORY and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metaboli

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.

  • Chemotherapy
  • China
  • Demand
  • Novartis AG
  • Sanofi-Synthelabo Inc.

Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.

  • Chemotherapy
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.

While oncology has been one of the most active therapeutic areas for drug development, for drugmakers the new cancer drugs have proven far more difficult to gain approval than medicines for infectious and autoimmune diseases.

  • Chemotherapy
  • World
  • Astellas Pharma Inc.
  • Medivation, Inc.
  • PROVENGE group

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Chemotherapy
  • China
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • Shenzhen Main Luck Pharmaceuticals Inc.

THIS STUDY INCLUDED BOTH PD-L## NEGATIVE TWO WEEKS) OR DOCETAXEL (##MG/ M (##%) AND PD-L## POSITIVE (##%) PATIENTS, BUT EXCLUDED PATIENTS WITH AUTOIMMUNE DISEASE, SYMPTOMATIC ILD, AND UNTREATED BRAIN METASTASIS.

  • Chemotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

(USA) ##.

  • Cancer
  • Chemotherapy
  • United States
  • World
  • Market Shares

THE SAFETY PROFILE OF TS-## AND GEMCITABINE + TS-## IN LOCALLY ADVANCED/ METASTATIC DISEASE WERE SIMILAR TO THOSE SEEN ON THE PATIENTS WITH RESECTED DISEASE.

  • Chemotherapy
  • AbbVie Inc.
  • AstraZeneca PLC
  • Halozyme Therapeutics, Inc.
  • Merck & Co., Inc.

Drivers and their Impact Driver Hospitals Pharmaceutical Stores Increase in Prevalence of Breast Cancer Low Low Unmet Medical Needs ## ## ## ## ## High High Low Low ## ## ## ## ## High High Increase in Prevalence of Breast Cancer Americas Low Low ## ## ## ## ## High High Low Low

  • Chemotherapy
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Hoffmann-La Roche Inc.

It offers its products and services to patients suffering with autoimmune diseases, liver diseases, and psoriasis, among others.

  • Chemotherapy
  • United States
  • World
  • Product Initiative
  • Cantex Pharmaceuticals, Inc.

It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and neurological diseases.

  • Chemotherapy
  • General Medicine And Specialty Medicine
  • United States
  • World
  • Product Initiative
  • BRISTOL-MYERS SQUIBB: KEY TAKEAWAYS
  • MARKET SHARE ANALYSIS 2014

The company develops drugs, using the genomic antibody drug discovery approach, in the areas of oncology, bone and joint diseases, CNS disorders, autoimmune diseases, and others.

  • Chemotherapy
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Sanofi S.A.

It is in preclinical stage of development for the treatment of autoimmune diseases.

  • Chemotherapy
  • Oncology
  • United States
  • Product Initiative
  • Immunovaccine Inc.
  • Investigators Information

Has a known additional malignancy that is progressing or requires active treatment Has known active central nervous system metastases and/ or carcinomatous meningitis Has an active autoimmune disease requiring systemic treatment within the past ## months or a documented history

  • Chemotherapy
  • Therapy
  • United States
  • World
  • Nerviano Medical Sciences Srl

Impaired Treg functions are linked with autoimmune diseases.

  • Cancer
  • Chemotherapy
  • United States
  • World
  • Product Initiative

One is a phase I trial vorinostat with intravenous temsirolimus for patients with metastatic disease.

  • Chemotherapy
  • Oncology
  • United States
  • World
  • Acetylon Pharmaceuticals, Inc.
  • PIPELINE BY MIMIVAX LLC, H1 2018

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2018 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Baculoviral inhibitor of apoptosis repeat-containing...

  • Chemotherapy
  • Hospital
  • Oncology
  • Therapy
  • Immunovaccine Inc.

It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases.

  • Chemotherapy
  • Lung Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • September 23, 2018.

Patients with active, non-infectious pneumonitis, an allogeneic transplant within the past five years (or more than five years but with graft-versus-host-disease [GVHD]), active autoimmune disease or a medical condition that required immunosuppression were ineligible for e

  • Chemotherapy
  • Lung Cancer
  • Therapy
  • United States
  • Merck & Co., Inc.
  • target action, date of April 3, 2018.

Only ## patient had progressive disease.

  • Chemotherapy
  • Hospital
  • Therapy
  • United States
  • Product Initiative
  • KEYTRUDA versus investigator-choice chemotherapy (paclitaxel, docetaxel, vinflunine) (HR, 0.73 [95 percent CI, 0.59, 0.91], p equal to 0.002).

Immune-mediated adverse events were autoimmune hemolytic anemia (n=##), colitis (n=##), hypothyroidism (n=##), and hypothyroidism (n=##).

  • Cancer
  • Chemotherapy
  • Therapy
  • United States
  • Product Initiative